# Calamus (Acorus calamus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/calamus
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 4 / 10
**Category:** Ayurveda
**Also Known As:** Acorus calamus, Sweet Flag, Sweet Root, Sweet Rush, Sweet Cane, Sweet Myrtle, Calamus Root, Flag Root, Rat Root, Sweet Sedge, Vacha, Bach, Ugragandha

## Overview

Calamus (Acorus calamus) is an Ayurvedic herb containing β-asarone as its primary bioactive compound. It demonstrates anti-diabetic activity through α-glucosidase inhibition and shows preliminary anticancer properties in laboratory studies.

## Health Benefits

• Potential anti-diabetic activity through α-glucosidase inhibition (stronger than acarbose in vitro studies)
• Possible anticancer properties showing 91-94% inhibition against cancer cell lines (preliminary in vitro evidence only)
• [Free radical scaveng](/ingredients/condition/antioxidant)ing antioxidant activity (demonstrated in DMSO leaf extract assays, no human studies)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects via RBC membrane stabilization (in vitro testing only)
• Antibacterial properties against various pathogens (limited to laboratory assays)

## Mechanism of Action

Calamus contains β-asarone and other phenolic compounds that inhibit α-glucosidase enzymes, potentially reducing postprandial glucose spikes. The herb's antioxidant activity stems from [free radical scaveng](/ingredients/condition/antioxidant)ing properties, while preliminary cancer cell studies suggest cytotoxic mechanisms through apoptosis induction. These effects appear mediated by the plant's volatile oils and phenolic constituents.

## Clinical Summary

Current evidence for calamus comes primarily from in vitro studies rather than human trials. Laboratory research shows α-glucosidase inhibition stronger than the diabetes drug acarbose, with 91-94% inhibition against certain cancer cell lines. [Antioxidant activity](/ingredients/condition/antioxidant) has been demonstrated in DMSO-based assays. However, robust human clinical trials are lacking, and most research remains at the preclinical stage, limiting definitive therapeutic claims.

## Nutritional Profile

Calamus rhizome contains minimal macronutrient value as a therapeutic herb used in small doses. Key bioactive compounds include: β-asarone (primary phenylpropanoid, up to 75-96% of essential oil in Asian varieties; notably absent or <0.1% in North American diploid variety), α-asarone (secondary phenylpropanoid constituent), and acorenone B (sesquiterpene ketone). Essential oil content ranges from 1.5-3.5% by dry weight of rhizome. Tannins present at approximately 1.5-2.0% dry weight. Starch content is substantial at 25-40% of dry rhizome weight, contributing minor caloric density. Bitter glycosides including acorin (~0.2%) contribute to digestive stimulant activity. Flavonoids present include luteolin and apigenin derivatives at trace concentrations (<0.1% dry weight). Galangin and other phenolic acids (ferulic acid, caffeic acid) identified in leaf and rhizome extracts. Minerals detected include moderate potassium, calcium (~150-200 mg/100g dry weight estimated), and trace iron. Crude fiber content approximately 5-8% dry weight. Bioavailability note: β-asarone bioavailability is high via lipophilic absorption; however, tetraploid Indian/Asian varieties contain carcinogenic β-asarone levels regulated by European health authorities (limit: 0.1 mg/kg in food). North American (diploid) variety is considered safer. Essential oil constituents are volatile and concentration-dependent on geographic origin, ploidy level, and extraction method.

## Dosage & Preparation

No clinically studied dosage ranges for humans have been established. Extraction yields include 1.58% volatile oil via hydro-distillation and 13.455% crude extract via dichloromethane:methanol maceration, but therapeutic dosing has not been standardized. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Calamus contains β-asarone, which has raised safety concerns due to potential carcinogenic properties in animal studies. The FDA has banned calamus in food products due to these safety issues. Pregnant and breastfeeding women should avoid calamus due to insufficient safety data. The herb may interact with diabetes medications by enhancing blood sugar-lowering effects, requiring medical supervision if used alongside antidiabetic drugs.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified in the available research. All evidence is limited to in vitro and animal studies examining pharmacological activities, with no PMIDs provided in the source material.

## Historical & Cultural Context

While noted as a wetland plant used for volatile oil extraction implying ethnobotanical interest, the research sources do not provide specific historical context or traditional medicine system usage. Traditional applications in systems like Ayurveda or TCM are not detailed in the available data.

## Synergistic Combinations

Ginger, turmeric, black pepper, cinnamon, green tea

## Frequently Asked Questions

### What is the main active compound in calamus?

The primary bioactive compound in calamus is β-asarone, a phenolic compound found in the plant's volatile oils. This compound is responsible for many of calamus's biological effects but has also raised safety concerns due to potential toxicity.

### Is calamus safe to use as a supplement?

The FDA has banned calamus in food products due to safety concerns about β-asarone's potential carcinogenic effects. While traditional use exists, modern safety data is limited, and medical supervision is recommended before use.

### How does calamus help with blood sugar control?

Calamus inhibits α-glucosidase enzymes, which break down carbohydrates into glucose. In laboratory studies, this inhibition was stronger than acarbose, a prescription diabetes medication, potentially helping reduce post-meal blood sugar spikes.

### What evidence exists for calamus anticancer properties?

Preliminary in vitro studies show calamus extracts inhibited 91-94% of certain cancer cell lines. However, these are only laboratory studies on isolated cells, not human trials, so clinical anticancer benefits remain unproven.

### Can calamus interact with diabetes medications?

Yes, calamus may enhance the blood sugar-lowering effects of diabetes medications due to its α-glucosidase inhibition properties. This could potentially lead to hypoglycemia, so medical supervision is essential if combining with antidiabetic drugs.

### What forms of calamus are available as supplements, and do they differ in effectiveness?

Calamus supplements are commonly available as dried root/rhizome powder, standardized extracts, and essential oils, though most clinical research has focused on aqueous or ethanol extracts of the rhizome. Standardized extracts may offer more consistent dosing of active compounds compared to raw powder, but direct comparative studies in humans are limited. The essential oil form carries higher concentration risk and is generally not recommended for internal supplementation due to potential toxicity concerns.

### Does calamus absorption improve when taken with food or on an empty stomach?

Limited human pharmacokinetic data exists for calamus supplements, though traditional use suggests taking it with warm water or mild meals to support digestive absorption. Fat-soluble components in calamus extracts may have improved bioavailability when consumed with dietary fat, but no peer-reviewed studies have directly tested timing or food interactions in human subjects. Individual absorption may vary based on extract type and gut health status.

### How does the strength of calamus evidence compare to other herbal anti-diabetic supplements?

Calamus shows promising in vitro α-glucosidase inhibition (reportedly stronger than the pharmaceutical acarbose), but lacks the rigorous human clinical trials that support established alternatives like bitter melon or fenugreek. Most calamus research remains preliminary, consisting primarily of cell culture and animal studies rather than controlled human trials, making direct efficacy comparisons difficult. For evidence-based diabetes support, herbs with published human RCTs (such as cinnamon or Gymnema sylvestre) may be preferred until larger-scale calamus studies are completed.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*